Clear ×
Vyome Holdings, Inc HIND

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Aug 28, 2026 8-K 3 signals fired
Other
Executive Educational Background Disclosure Employee Director Compensation Waiver
Core
Management Exodus
Aug 25, 2026 8-K 6 signals fired
Core
Clinical Trial Result Clinical Hold Indication Expansion
Other
Interim Data Positive Patient Retention High
Biotech Risk
Crl Received
Aug 12, 2026 10-Q 17 signals fired · top 15
Other
Net Loss Reported Depreciation Expense Composition Disclosure Ipo Or Capital Raising Completion Financing Activities Cash Flow Disclosure Operating Lease Rent Expense Disclosed Interest Income Year Over Year Comparison Valuation Allowance Deferred Tax Disclosure Nyse Listing Disclosure Liquidity Position Snapshot Disclosed Reverse Stock Split Effected Nol Carryforward Expiration Disclosure Stock Option Intrinsic Value Disclosure
Core
Regulatory Designation Only Indication Expansion Lead Asset Progress
May 29, 2026 8-K 4 signals fired
Core
Regulatory Designation Only Indication Expansion Clinical Hold
Biotech Risk
Clinical Hold Active
May 12, 2026 10-Q 30 signals fired · top 15
Other
Reverse Stock Split Effected Depreciation Expense Composition Disclosure Net Loss Reported Ipo Or Capital Raising Completion Operating Lease Rent Expense Disclosed Lease Rou Incremental Borrowing Rate Disclosure Arbitrator Selection Procedure Interest Income Year Over Year Comparison Equity Plan Board Approval Conditional On Shareholder Vote Fair Value Hierarchy Disclosure Financing Activities Cash Flow Disclosure Valuation Allowance Deferred Tax Disclosure Director Officer Indemnification Provision Nonqualified Stock Option Exercise Or Grant
Core
Indication Expansion
Mar 18, 2026 10-K 54 signals fired · top 15
Other
Auditor Appointment Ratification Executive Educational Background Disclosure Audit Committee Independence Certification Deferred Tax Asset Valuation Disclosure Capital Raising Uncertainty Disclosed Restrictive Debt Covenants Disclosure Classified Board Director Election Reverse Stock Split Effected Net Loss Reported Committee Meeting Attendance Disclosure Ipo Or Capital Raising Completion Code Of Conduct Adoption Disclosure Material Weakness In Internal Controls Disclosed Cybersecurity Risk Management Program Disclosure Market Volatility Risk Disclosure